A detailed history of Freedom Day Solutions, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Freedom Day Solutions, LLC holds 5,909 shares of VRTX stock, worth $2.66 Million. This represents 0.86% of its overall portfolio holdings.

Number of Shares
5,909
Previous 5,891 0.31%
Holding current value
$2.66 Million
Previous $2.76 Million 0.47%
% of portfolio
0.86%
Previous 0.94%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$460.0 - $505.78 $8,280 - $9,104
18 Added 0.31%
5,909 $2.75 Million
Q2 2024

Jul 19, 2024

BUY
$392.81 - $485.53 $93,095 - $115,070
237 Added 4.19%
5,891 $2.76 Million
Q1 2024

Apr 24, 2024

SELL
$407.69 - $446.08 $22,015 - $24,088
-54 Reduced 0.95%
5,654 $2.36 Million
Q4 2023

Jan 29, 2024

BUY
$343.0 - $410.68 $338,198 - $404,930
986 Added 20.88%
5,708 $2.32 Million
Q3 2023

Oct 25, 2023

BUY
$338.18 - $362.46 $38,890 - $41,682
115 Added 2.5%
4,722 $1.64 Million
Q2 2023

Jul 24, 2023

BUY
$314.42 - $351.91 $55,337 - $61,936
176 Added 3.97%
4,607 $1.62 Million
Q1 2023

Apr 24, 2023

BUY
$283.23 - $323.1 $178,151 - $203,229
629 Added 16.54%
4,431 $1.4 Million
Q4 2022

Feb 07, 2023

BUY
$285.76 - $321.48 $1.09 Million - $1.22 Million
3,802 New
3,802 $1.1 Million
Q2 2021

Aug 13, 2021

SELL
$187.49 - $221.1 $320,045 - $377,417
-1,707 Closed
0 $0
Q1 2021

May 10, 2021

BUY
$207.02 - $241.31 $53,411 - $62,257
258 Added 17.81%
1,707 $367,000
Q4 2020

Jan 28, 2021

SELL
$207.01 - $276.09 $596,188 - $795,139
-2,880 Reduced 66.53%
1,449 $342,000
Q3 2020

Oct 26, 2020

SELL
$255.65 - $303.1 $26,331 - $31,219
-103 Reduced 2.32%
4,329 $1.17 Million
Q2 2020

Jul 27, 2020

BUY
$225.48 - $295.8 $999,327 - $1.31 Million
4,432 New
4,432 $1.29 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Freedom Day Solutions, LLC Portfolio

Follow Freedom Day Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Freedom Day Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Freedom Day Solutions, LLC with notifications on news.